When the HMT function of SET1/MLL is inhibited, it can reduce the levels of H3K4me3 in the prefrontal cortex (PFC), restore the expression of glutamate receptor at synapses, increase PFC synaptic plasticity, and further improve cognitive impairment in AD mice. The gene discussed is KMT2A; the disease is Alzheimer disease.